Resmed Inc Stock Ownership - Who owns Resmed?

Insider buying vs selling

Have Resmed Inc insiders been buying or selling?
Karen DrexlerDirector2023-02-02594$226.58
Michael J. FarrellChief Executive Officer2023-01-175,675$57.76
Robert Andrew DouglasPresident and COO2023-01-171,500$220.43
Michael J. FarrellChief Executive Officer2023-01-175,675$224.36
David PendarvisChief Administrative Officer2023-01-031,500$210.07
Michael J. FarrellChief Executive Officer2022-12-155,675$215.64
Michael J. FarrellChief Executive Officer2022-12-155,675$57.76
David PendarvisChief Administrative Officer2022-12-051,500$229.81
David PendarvisChief Administrative Officer2022-11-25683$146.34
David PendarvisChief Administrative Officer2022-11-236,911$224.40

1 of 10

RMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RMD insiders and whales buy or sell their stock.

RMD Shareholders

What type of owners hold Resmed Inc stock?
Vanguard Group Inc11.07%16,261,844$3.65BInstitution
Blackrock Inc9.09%13,353,727$3.00BInstitution
Fmr LLC4.96%7,290,515$1.64BInstitution
State Street Corp4.39%6,456,315$1.45BInstitution
Wcm Investment Management LLC3.96%5,816,958$1.31BInstitution
Capital World Investors3.35%4,921,954$1.11BInstitution
Geode Capital Management LLC2.06%3,033,561$681.34MInstitution
Northern Trust Corp1.28%1,877,768$421.75MInstitution
Christopher G. Roberts1.16%1,700,337$381.90MInsider
Invesco Ltd1.11%1,635,519$367.34MInstitution

1 of 3

RMD vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RMD64.58%4.34%Net SellingNet Selling
BAX84.13%15.87%Net SellingNet Buying
STE92.36%0.94%Net SellingNet Selling
HOLX87.32%12.68%Net SellingNet Selling

Resmed Stock Ownership FAQ

Who owns Resmed?

Resmed (NYSE: RMD) is owned by 64.58% institutional shareholders, 4.34% Resmed insiders, and 31.08% retail investors. Christopher G. Roberts is the largest individual Resmed shareholder, owning 1.70M shares representing 1.16% of the company. Christopher G. Roberts's Resmed shares are currently valued at $381.90M.

If you're new to stock investing, here's how to buy Resmed stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.